跳至主要内容
临床试验/NCT00889031
NCT00889031已完成不适用

Protocol to Obtain Blood Samples for Leukemia Research

Dartmouth-Hitchcock Medical Center1 个研究点 分布在 1 个国家目标入组 187 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
187
试验地点
1
主要终点
To determine the frequency with which CLL cells incubated ex vivo with vincristine undergo rapid interphase apoptosis.

研究概览

简要总结

The purpose of this study is to collect a blood sample in patients with Chronic Lymphocytic Leukemia (CLL).

详细描述

The blood sample will be used in the laboratory to perform studies focusing on Chronic Lymphocytic Leukemia (CLL).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing routine blood draws as part of their ongoing follow-up for Chronic Lymphocytic Leukemia (CLL) at the Norris Cotton Cancer Center of DHMC.

排除标准

  • Patients who have received cytotoxic drug, oral or intravenous steroid or targeted antibody therapy for CLL or other disease process within the past 6 months are excluded. Use of intravenous immunoglobulin (IVIg) is not a reason for exclusion.

结局指标

主要结局

To determine the frequency with which CLL cells incubated ex vivo with vincristine undergo rapid interphase apoptosis.

时间窗: 2 Years

次要结局

  • To determine whether suppression or inhibition of BCL2 family members can acutely sensitize CLL cells to vincristine.(2 Years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher H. Lowrey

Professor of Medicine and of Pharmacology and Toxicology

Dartmouth-Hitchcock Medical Center

研究点 (1)

Loading locations...

相似试验